These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 18095744)

  • 1. Methods for causality assessment of adverse drug reactions: a systematic review.
    Agbabiaka TB; Savović J; Ernst E
    Drug Saf; 2008; 31(1):21-37. PubMed ID: 18095744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
    Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
    Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
    Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
    Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?
    Macedo AF; Marques FB; Ribeiro CF
    Drug Saf; 2006; 29(8):697-702. PubMed ID: 16872243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement of expert judgment in causality assessment of adverse drug reactions.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Moore N; Molimard M; Haramburu F
    Eur J Clin Pharmacol; 2005 May; 61(3):169-73. PubMed ID: 15827761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imputation of adverse drug reactions: Causality assessment in hospitals.
    Varallo FR; Planeta CS; Herdeiro MT; Mastroianni PC
    PLoS One; 2017; 12(2):e0171470. PubMed ID: 28166274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.
    Ohta M
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1443-1452. PubMed ID: 33829295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.
    Pradhan P; Lavallee M; Akinola S; Escobar Gimenes FR; Berard A; Methot J; Piche ME; Gonella JM; Cloutier L; Leclerc J
    J Appl Biomed; 2023 Jun; 21(2):59-66. PubMed ID: 37376882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
    Rodrigues PP; Ferreira-Santos D; Silva A; Polónia J; Ribeiro-Vaz I
    Artif Intell Med; 2018 Sep; 91():12-22. PubMed ID: 30077492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.
    Goldman JL; Chung WH; Lee BR; Chen CB; Lu CW; Hoetzenecker W; Micheletti R; Yasuda SU; Margolis DJ; Shear NH; Struewing JP; Pirmohamed M
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1135-1141. PubMed ID: 30918988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.
    Macedo AF; Marques FB; Ribeiro CF; Teixeira F
    J Clin Pharm Ther; 2003 Apr; 28(2):137-43. PubMed ID: 12713611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principle of adverse drug reaction causality judgement and interpretation of causality assessment method both in China and abroad].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2744-7. PubMed ID: 23285925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.
    Gallagher RM; Kirkham JJ; Mason JR; Bird KA; Williamson PR; Nunn AJ; Turner MA; Smyth RL; Pirmohamed M
    PLoS One; 2011; 6(12):e28096. PubMed ID: 22194808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.
    Khan LM; Al-Harthi SE; Osman AM; Sattar MA; Ali AS
    Saudi Pharm J; 2016 Jul; 24(4):485-93. PubMed ID: 27330379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions.
    Cherkas Y; Ide J; van Stekelenborg J
    Drug Saf; 2022 May; 45(5):571-582. PubMed ID: 35579819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
    Comfort S; Dorrell D; Meireis S; Fine J
    Drug Saf; 2018 Nov; 41(11):1073-1085. PubMed ID: 29876835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.